✦ LIBER ✦

1.P.200 Market reduction of LDL-apheresis by treatment with LDL-apheresis and atorvastatin in a case of homozygous familial hypercholesterolemia (FH)

✍ Scribed by Y. Mikami; Y. Homma; K. Tagata

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decrease of LDL-apheresis frequency with

✍ D. Erlich; A. Chiali; A. Warnet; D. Farges; Y. Goussault; A. Bussel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Treatment of homozygous familial hyperch

✍ Palcoux, J.B.; Meyer, M.; Jouanel, P.; Tridon, A.; Vanlieferinghen, P.; Carla, H 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 312 KB

Effect of LDL-apheresis with dextran sul

✍ P. Edigio; E. Avelar; E. Veríssimo; A. Gaspar; M. Bruges; F. Crespo; P. Machado; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Elevated serum MMP-9/TIMP-1 ratio in pat

✍ Marit S. Nenseter; Ingunn Narverud; Asgeir Græsdal; Martin P. Bogsrud; Bente Hal 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 249 KB

1.P.212 Atorvastatin therapy for treatme

✍ H. Sinzinger; Susanne Granegger; A. Ferlitsch 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 177 KB

1.P.214 The long-term effect of LDL aphe

✍ Y. Takeda; K. Saku; K. Liu; T. Ohta; B. Zhang; S. Jimi; K. Arakawa 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 177 KB